Results 11 to 20 of about 4,112 (160)

Clinical utility gene card for: hyperlipoproteinemia, TYPE II. [PDF]

open access: yesEur J Hum Genet, 2014
Kassner U   +5 more
europepmc   +5 more sources

Milky Plasma, Murky Diagnosis: Urgent Plasma Exchange for Severe Hypertriglyceridemia-Induced Hyperviscosity Without Pancreatitis, but With Myocardial Infarction. [PDF]

open access: yesJ Clin Apher
ABSTRACT Severe hypertriglyceridemia can increase the risk of acute pancreatitis, but also clinically significant hyperviscosity syndrome characterized by the typical signs of neurologic and visual manifestations. Hyperviscosity syndrome is a well‐established medical emergency.
Bodnar C   +3 more
europepmc   +2 more sources

2022 Consensus statement on the management of familial hypercholesterolemia in Korea [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2022
Familial hypercholesterolemia (FH) is the most common monogenic disorder. Due to the marked elevation of cardiovascular risk, the early detection, diagnosis, and proper management of this disorder are critical.
Chan Joo Lee   +6 more
doaj   +1 more source

Diffuse plane xanthomas as the first manifestation of multiple myeloma. [PDF]

open access: yesJ Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 11, Page 1451-1453, November 2025.
Koutra E   +5 more
europepmc   +2 more sources

Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia [PDF]

open access: yesEndocrinology and Metabolism, 2021
Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and ...
Brian Tomlinson   +3 more
doaj   +1 more source

Familial hypercholesterolemia within cardiology practice – single-center experience during 2-year period

open access: yesResearch in Cardiovascular Medicine, 2022
Background: Familial hypercholesterolemia (FH) is an inherited disorder characterized by significantly elevated levels of low-density lipoprotein (LDL) cholesterol and is usually diagnosed after the occurrence of major adverse cardiovascular event.
Edin Begic   +17 more
doaj   +1 more source

Diagnostic Utility of Liver Biopsy in Persistent Unexplained Liver Enzyme Elevation: A Retrospective Cohort Study. [PDF]

open access: yesJGH Open
ABSTRACT Background and Aims Chronically elevated liver enzymes without a clear etiology remain a frequent diagnostic challenge. This study evaluated the diagnostic yield of liver biopsy in such cases and assessed if laboratory parameters predict histological clarification. Methods We retrospectively analyzed 71 patients with unexplained elevated liver
Jaawan S   +8 more
europepmc   +2 more sources

Pseudohomozygous type II hyperlipoproteinemia [PDF]

open access: yesJapanese journal of human genetics, 1982
A 12-month-old boy with clinical findings suggestive of homozygous familial hypercholesterolemia, who had no secondary causes of hypercholesterolemia, and whose parents had no lipid abnormalities, was reported. No abnormalities were noted in the low density lipoprotein (LDL) receptor activities of the fibroblasts from patient, parents and sibling.
K, Hamada   +8 more
openaire   +2 more sources

Molecular diagnosis methods in familial hypercholesterolemia

open access: yesAnatolian Journal of Cardiology, 2020
Familial hypercholesterolemia (FH) is considered the genetic cause of coronary heart disease and ischemic stroke. FH is mainly an autosomal codominant pattern-based disorder and is primarily determined by point mutations within the low-density ...
Valeriu Moldovan   +2 more
doaj   +1 more source

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia [PDF]

open access: yesDiabetes & Metabolism Journal, 2015
Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and ...
Klaus G. Parhofer
doaj   +1 more source

Home - About - Disclaimer - Privacy